Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 33

M&A

Discipline Crucial in 2020

By Alexandra Garfinkle
|
Published: December 2nd, 2019
M&A valuations remain frothy and Ebitda adjustments are growing, panelists cautioned at The 2019 Deal Economy Conference.
Activism

Vitamin Shoppe to Emphasize Organic Growth

By Alexandra Garfinkle
|
Published: December 2nd, 2019
Vitamin Shoppe GC David Kastin said that the company will pursue organic growth, while its soon-to-be parent pursues M&A.
Activism

Activists Find New Routes to M&A Opportunities

By Ronald Orol
|
Published: December 2nd, 2019
Insurgent managers are targeting larger companies and are taking on different roles, a panel of experts told The Deal Economy's 2019 conference.
Activism

M&A, Politics, SEC Top of Mind for Activists

By Ronald Orol
|
Published: December 2nd, 2019
Schulte Roth partner Aneliya Crawford discusses activism at large-cap companies, BMY-Celgene and insurgent prospects in a second Trump or Warren administration at The Deal Economy conference.
M&A

Pfizer Leans Toward Tuck-In Deals

By Armie Margaret Lee
|
Published: November 27th, 2019
This year, Pfizer’s first under the leadership of Albert Bourla, the biopharma company has done deals including the purchase of Array BioPharma and Therachon.
Activism

Lawyers Debate Icahn-Oxy Feud

By Greg Morcroft
|
Published: November 27th, 2019
Sidley's Kai Liekefett and Schulte's Ele Klein diverge in their opinions about Carl Icahn’s unyielding agitation at Occidental Petroleum.
M&A

M&A Can Make All Companies Tech Companies

By Tom Terrarosa
|
Published: November 27th, 2019
Companies in centuries-old industries ranging from real estate to agriculture to education are grappling with the issue of how to become technology-enabled, according to a panel at The Deal Economy Conference.
M&A

More Diligence, Insurance Needed to Mitigate Risk

By Michael Brown
|
Published: November 27th, 2019
Panelists at The Deal Economy Conference said greater use of due diligence, reps and warranty insurance and other tools is needed to mitigate risk in today's M&A deals.
Activism

L Brands Meets With Bankers as Mitarotonda Watches

By Ronald Orol
|
Published: November 26th, 2019
The Victoria’s Secret and Bath & Body Works owner could soon be under pressure once again from activist investor Barington Capital if a deal doesn’t happen first.